Key facts
- BTAI - BioXcel Therapeutics, Inc. has 33 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 33 Insiders of BioXcel Therapeutics, Inc.
- Symbol
- BTAI on Nasdaq
- Location
- New Haven, CT
Change
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
BioXcel Therapeutics, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Vipin Agarwal | 10%+ Owner | $187,267,747 | Mixed | 03 Apr 2023 | ||
| Rashmi Agarwal | 10%+ Owner | $187,267,747 | Mixed | 03 Apr 2023 | ||
| Tarun K. Gupta | 10%+ Owner | $187,168,169 | Mixed | 03 Apr 2023 | ||
| Indu R. Gupta | 10%+ Owner | $187,168,169 | Mixed | 03 Apr 2023 | ||
| Suganthi Balasubramanian | 10%+ Owner | $187,110,248 | Mixed | 03 Apr 2023 | ||
| Anita Jain | 10%+ Owner | $187,100,398 | Mixed | 03 Apr 2023 | ||
| Diwakar Jain | 10%+ Owner | $187,100,398 | Mixed | 03 Apr 2023 | ||
| Michael James Aiello | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Anesha Agarwal | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Pardeep Kumar Sood | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Marshal D. Gibson | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Krishnan Nandabalan | Director, 10%+ Owner | $187,088,358 | Mixed | 06 Apr 2023 | ||
| BioXcel Holdings, Inc. | 10%+ Owner | $187,088,358 | Mixed | 25 Jun 2021 | ||
| BioXcel LLC | 10%+ Owner | $187,088,358 | Mixed | 25 Jun 2021 | ||
| Akrati Agarwal | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Bina Jatin Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Jatin Markand Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Krunal Dilip Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Alka Sood | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Ph.D. Vimal Mehta | CEO and President, Director | $697,281 | Mixed | 01 May 2026 | ||
| David J. Mack | Director | $56,212 | Mixed | 09 Jan 2026 | ||
| Javier Rodriguez | Chief Legal Officer, Senior Vice President and Corporate Secretary | $21,392 | Mixed | 01 May 2026 | ||
| Richard I. Steinhart | Chief Financial Officer | $21,100 | Mixed | 01 May 2026 | ||
| Ph.D Frank Yocca | Chief Scientific Officer | $20,932 | Mixed | 01 May 2026 | ||
| Matthew T. Wiley | Chief Commercial Officer | $20,056 | Mixed | 17 Sep 2024 | ||
| Vincent O'Neill | Executive Vice President, Chief of Product Development and Medical Officer | $7,975 | Mixed | 14 Dec 2024 | ||
| Michael Patrick Miller | Director | Mixed | 09 Jan 2026 | |||
| Rajiv Patni | Director | Mixed | 09 Jan 2026 | |||
| William P. Kane Jr. | Chief Commercial Officer | Mixed | 16 Aug 2021 | |||
| June Bray | Director | Mixed | 09 Jan 2026 | |||
| Sandeep Laumas | Director | Mixed | 09 Jan 2026 | |||
| Michal Votruba | Director | Mixed | 09 Jan 2026 | |||
| Peter Mueller | Director | Mixed | 09 Jan 2026 |
Top shareholders of BioXcel Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
8.4%
|
1,835,192
|
$3,762,144 | +$1,654,635 | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
7%
from 13D/G
|
1,910,076
|
$2,559,502 | — | 31 Mar 2026 | |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
|
Oaktree Capital Holdings, LLC |
2.7%
|
170,230
|
$28,939 | -$434,154 | 31 Mar 2025 | |
| Qatar Investment Authority |
13D/G
|
— |
0.6%
|
156,066
|
$26,531 | -$436,562 | 31 Dec 2025 | |
| Ph.D. Vimal Mehta |
3/4/5
|
CEO and President, Director |
2.4%
|
519,727
mixed-class rows
|
$697,281 | — | 01 May 2026 | |
| Richard I. Steinhart |
3/4/5
|
Chief Financial Officer |
0.07%
|
15,645
mixed-class rows
|
$21,100 | — | 01 May 2026 | |
| Ph.D Frank Yocca |
3/4/5
|
Chief Scientific Officer |
0.07%
|
15,520
mixed-class rows
|
$20,932 | — | 01 May 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
8.9%
|
1,936,760
|
$2,595,258 | — | 31 Mar 2026 | |
| OAKTREE CAPITAL MANAGEMENT LP |
13F
|
Company |
1.1%
|
241,188
|
$323,193 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
230,168
|
$308,725 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.95%
|
207,339
|
$277,834 | — | 31 Mar 2026 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0.6%
|
131,789
|
$166,054 | — | 31 Mar 2026 | |
| Man Group plc |
13F
|
Company |
0.44%
|
96,473
|
$129,274 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.42%
|
92,118
|
$123,438 | — | 31 Mar 2026 | |
| FMR LLC |
13F
|
Company |
0.41%
|
90,300
|
$121,002 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.39%
|
84,921
|
$113,794 | — | 31 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
0.39%
|
84,282
|
$112,938 | — | 31 Mar 2026 | |
| &PARTNERS |
13F
|
Company |
0.37%
|
80,864
|
$108,358 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
52,788
|
$70,736 | — | 31 Mar 2026 | |
| Oaktree Fund Advisors, LLC |
13F
|
Company |
0.2%
|
42,913
|
$57,503 | — | 31 Mar 2026 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.19%
|
41,000
|
$54,940 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
36,313
|
$48,659 | — | 31 Mar 2026 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.09%
|
18,877
|
$25,296 | — | 31 Mar 2026 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.07%
|
16,214
|
$21,726 | — | 31 Mar 2026 | |
| DIVERSIFY WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
15,000
|
$15,600 | — | 31 Mar 2026 | |
| Portfolio Strategies, Inc. |
13F
|
Company |
0.06%
|
12,178
|
$16,319 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
10,588
|
$14,188 | — | 31 Mar 2026 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
4,319
|
$5,787 | — | 31 Mar 2026 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,718
|
$2,302 | — | 31 Mar 2026 | |
| Vanguard Global Advisers, LLC |
13F
|
Company |
0%
|
493
|
$661 | — | 31 Mar 2026 | |
| Silver Grove Financial Group, Inc. |
13F
|
Company |
0%
|
334
|
$447 | — | 31 Mar 2026 | |
| Washington Trust Advisors, Inc. |
13F
|
Company |
0%
|
160
|
$214 | — | 31 Mar 2026 | |
| Annis Gardner Whiting Capital Advisors, LLC |
13F
|
Company |
0%
|
156
|
$210 | — | 31 Mar 2026 | |
| Parkside Financial Bank & Trust |
13F
|
Company |
0%
|
112
|
$151 | — | 31 Mar 2026 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
60
|
$80 | — | 31 Mar 2026 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
59
|
$79 | — | 31 Mar 2026 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
45
|
$54 | — | 31 Mar 2026 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
25
|
$31 | — | 31 Mar 2026 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
21
|
$28 | — | 31 Mar 2026 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
14
|
$19 | — | 31 Mar 2026 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
13
|
$17 | — | 31 Mar 2026 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0%
|
2
|
$3 | — | 31 Mar 2026 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2026 | |
| Triumph Capital Management |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2026 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2026 | |
| Rashmi Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Vipin Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Indu R. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Tarun K. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Suganthi Balasubramanian |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,750
|
$187,110,248 | — | 03 Apr 2023 |
Recent Insider Transactions by Companies or Individuals for BioXcel Therapeutics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 84.7% | 18,000 | 39,259 | 01 May 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -100% | -18,000 | 0 | 01 May 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 135.4% | 9,000 | 15,645 | 01 May 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -100% | -9,000 | 0 | 01 May 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 138% | 9,000 | 15,520 | 01 May 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -100% | -9,000 | 0 | 01 May 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 131.1% | 9,000 | 15,863 | 01 May 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -100% | -9,000 | 0 | 01 May 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 1.04% | 219 | 21,259 | 15 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -12.5% | -219 | 1,532 | 15 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.53% | 35 | 6,645 | 15 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.51% | 35 | 6,863 | 15 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.54% | 35 | 6,520 | 15 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 0.79% | 164 | 21,040 | 14 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -25.2% | -164 | 488 | 14 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.5% | 33 | 6,610 | 14 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.49% | 33 | 6,828 | 14 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.51% | 33 | 6,485 | 14 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Sandeep Laumas | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Rajiv Patni | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Peter Mueller | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Michal Votruba | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Michael Patrick Miller | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| June Bray | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| David J. Mack | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Award | 24822.7% | 70,000 | 70,282 | 01 Jan 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Award | 24822.7% | 70,000 | 70,282 | 01 Jan 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Award | 11366.8% | 199,032 | 200,783 | 01 Jan 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Award | 24822.7% | 70,000 | 70,282 | 01 Jan 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 1.06% | 219 | 20,876 | 15 Dec 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -11.1% | -219 | 1,751 | 15 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.54% | 35 | 6,577 | 15 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -11% | -35 | 282 | 15 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.52% | 35 | 6,795 | 15 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -11% | -35 | 282 | 15 Dec 2025 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.55% | 35 | 6,452 | 15 Dec 2025 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -11% | -35 | 282 | 15 Dec 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 0.8% | 164 | 20,657 | 14 Dec 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -20.1% | -164 | 652 | 14 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.51% | 33 | 6,542 | 14 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -20.2% | -33 | 130 | 14 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.49% | 33 | 6,760 | 14 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -20.2% | -33 | 130 | 14 Dec 2025 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.52% | 33 | 6,417 | 14 Dec 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.